EUVIMEDEUVIMED entdecken
Crossref

Arachidonic Acid and Lipoxin A4 Protect Pancreatic β‐Cells and Improve Hyperglycemia Induced by Bleomycin

Sailaja Polavarapu, Poorani Rhenghachar, Undurti N Das iD

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.70745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Sailaja Polavarapu und 2 weiteren Autor:innen. Beteiligte Einrichtung: BioScience Research Centre, GVP Engineering College, Visakhapatnam, India. Hauptthemen laut MEDLINE: Lipoxins, Bleomycin, Insulin-Secreting Cells, Hyperglycemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study was conducted to examine whether bleomycin‐induced growth inhibitory action on rat insulinoma cells (RIN5F) in vitro and hyperglycemia in female Wistar rats is influenced by arachidonic acid (AA) and its anti‐inflammatory metabolite: lipoxin A4 (LXA4). The in vitro study was conducted using RIN5F cells. The potential of various PUFAs (polyunsaturated fatty acids), eicosanoids and LXA4, resolvin D1 and protectin D1 to modify the growth inhibitory effects of bleomycin was measured by MTT assay. In an in vivo study, we tested the effect of AA and LXA4 on bleomycin‐induced hyperglycemia in female Wistar rats. We noted that of all the PUFAs and their metabolites tested, AA (10 µg/mL) and LXA4 (1 ng/mL) are the most effective in protecting RIN5F cells against bleomycin induced growth suppression. An increase in LXA4 levels was noted when RIN5F cells were supplemented with AA. Bleomycin induced a significant increase in the fasting blood glucose levels and decreased plasma insulin levels that were reverted to normal by LXA4 (50 ng/animal). AA (50 μg/animal) and LXA4 improved the antioxidant status and upregulated anti‐inflammatory and anti‐apoptotic genes IκB and Bcl2. These results suggest AA and LXA4 can prevent bleomycin‐induced dysfunction of pancreatic β cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipoxinsBleomycinInsulin-Secreting CellsHyperglycemiaArachidonic AcidAnimalsFemaleRatsRats, WistarSpecialized Pro-Resolving MediatorsCell Line, Tumor

Stichwörter der Autor:innen

arachidonic acidbleomycinlipoxin A4pancreatic β cell functionplasma insulinrat insulinoma cells

Substanzen

Lipoxinslipoxin A4BleomycinArachidonic Acid

Autor:innen und Institutionen

  • BioScience Research Centre, GVP Engineering College, Visakhapatnam, India.
  • UND Life Sciences, Battle Ground, Washington, USA.
  • Department of Biotechnology, Indian Institute of Technology-Hyderabad, Sangareddy, India.
  • Department of Medicine, Omega Hospitals, Gachibowli, Hyderabad, India.

ORCID-Profile: Undurti N Das

Zitieren

APA

Polavarapu, S., Rhenghachar, P., & Das, U. N. (2026). Arachidonic Acid and Lipoxin A4 Protect Pancreatic β‐Cells and Improve Hyperglycemia Induced by Bleomycin. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70745

Vancouver

Polavarapu S, Rhenghachar P, Das UN. Arachidonic Acid and Lipoxin A4 Protect Pancreatic β‐Cells and Improve Hyperglycemia Induced by Bleomycin. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70745

BibTeX
@article{Polavarapu2026,
  author = {Polavarapu, Sailaja and Rhenghachar, Poorani and Das, Undurti N},
  title = {Arachidonic Acid and Lipoxin A4 Protect Pancreatic β‐Cells and Improve Hyperglycemia Induced by Bleomycin},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.70745}
}
Kostenlos starten →